Trial site
MD Anderson Cancer Center Madrid
- 6running trials
- 7closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia3 trials
- Colorectal cancer2 trials
- Endometrial cancer2 trials
- Neuroendocrine tumours2 trials
- Pancreatic cancer2 trials
- Kidney cancer1 trial
- Lung cancer1 trial
- Metastatic breast cancer1 trial
- Myelodysplastic syndromes1 trial
- Ovarian cancer1 trial
- Prostate cancer1 trial
- Thyroid cancer1 trial
- and 1 more
- Phase
- Phase 25 trials
- Phase 35 trials
- Phase 1/23 trials
- Status
- Active, not recruiting4 trials
- Terminated4 trials
- Completed3 trials
- Recruiting2 trials
- Lead sponsor
- Artios Pharma Ltd1 trial
- Camurus AB1 trial
- Eisai Inc.1 trial
- Gilead Sciences1 trial
- Grupo Espanol de Tumores Neuroendocrinos1 trial
- and 8 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Active, not recruiting
Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
- Thyroid cancer1 recruiting
Closed trials
Terminated
Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML
Terminated
A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer
Terminated
Terminated
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026